Sight
Argus II becomes first "bionic eye" to gain approval for sale in U.S.
While the word prosthesis usually evokes images of artificial legs, arms, and these days even sophisticated thought-controlled hands, an entirely new class of replacement body part has now become a reality – the bionic eye. One of the pioneers in this field is California-based Second Sight and the company has now announced that its Argus II System has received U.S. market approval from the Food and Drug Administration (FDA). Read More
There could be new hope for people facing vision loss due to conditions such as retinitis pigmentosa or wet age-related macular degeneration. Scientists from the University of Southampton have discovered that easily-gathered corneal cells may be able to take the place of degraded retinal cells, thus preventing or curing blindness. Read More
Age-related macular degeneration is the leading cause of blindness in North America, while retinitis pigmentosa causes approximately 1.5 million people worldwide to lose their sight every year. Individuals afflicted with retinal degenerative diseases such as these might someday be able to see again, however, thanks to a device being developed at California’s Stanford University. Scientists there are working on a retinal prosthesis, that uses what could almost be described as miniature solar panels to turn light signals into nerve impulses. Read More
The Argus II Retinal Implant from California-based company Second Sight has become the first retinal prosthesis for treatment of the blind approved for sale in Europe. The approval follows a successful clinical trial that ran for almost four years and saw more than 30 patients around the world using the device at home as they went about their daily lives. While the system isn’t able to restore normal vision, the majority of trial subjects gained the ability to perceive colors, recognize large letters and locate objects, while two were even able to read short sentences. Read More
What do trees, rivers, clouds and neurons have in common? They're all examples of fractals, or irregularly-shaped objects in which any one component is the same shape as the whole – a tributary of a river, for instance, looks like a miniature river itself. Electronic chips are not fractals, yet some researchers are trying to restore sight to the blind by attaching such chips to the eye's neurons. Given that neurons are fractals, wouldn't it work better to hook them up to other fractal structures? University of Oregon researcher Richard Taylor thinks so, which is why he's developing metal "nanoflowers." Read More
If you suffer from hyperopia, more commonly known as farsightedness or longsightedness, you may be interested to know that the world's first contact lens to correct the condition has been developed. The correction, however, is temporary – a custom-made lens is worn overnight to reshape the cornea, and when the patient wakes up and removes the lens they have perfect vision for the day. Read More
After five years, the U.S. Food and Drug Administration has finally given approval to an eye telescope that treats macular degeneration, the leading cause of blindness in the U.S. The Implantable Miniature Telescope (IMT) has been developed by VisionCare Ophthalmic Technologies, Inc. as part of Centrasight, a new patient care system which treats end-stage age-related macular degeneration (AMD). Read More
In another world first in the fight against degenerative eye disorders, scientists from the Universtiy of California, Irvine, have created an eight-layer early-stage retina from human embryonic stem cells. Not only is this the world's first three-dimensional complex tissue structure to be made from stem cells, but it also marks the first step toward the development of transplant-ready retinas to treat eye disorders affecting millions. Read More
Donor corneas are extremely rare, but for 40,000 people in Europe corneal transplantation from donors offer the only hope of addressing blindness in one or both eyes. That was, until Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm created the first artificial cornea. Read More
Scientists at the California Institute of Technology (Caltech) have created a remote-controlled robot to help test the effectiveness of visual prostheses, such as an artificial retina, which are implanted into visually-impaired patients. Cyclops the robot - or, rather, the mobile robotic platform, or rover - lets scientists “see” the results that human patients could expect without having to test the device on them first. It is hoped that this approach may spare them some unnecessary procedures and one day lead to giving blind people the freedom of independence. Read More
